Product Images Xelstrym

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 24 images provide visual information about the product associated with Xelstrym NDC 68968-0215 by Noven Therapeutics, Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

chemical structure - xelstrym 01

Figure1 - xelstrym 02

figure2 - xelstrym 03

figure3 - xelstrym 04

This appears to be a table of data related to a study of a medication's effects on different populations. It includes information on age ranges (65-74 and greater than or equal to 75), gender, and different levels of renal impairment. There are also measurements provided for PK (pharmacokinetics) including Cmax and AUC, as well as fold change and 90% CI. However, without additional context it is not possible to know the specific medication or implications of these findings.*

figure4 - xelstrym 05

This text appears to be a list of drugs and their interaction with certain enzymes in the body. Guanfacine and Venlafaxine are interacting drugs, and other drugs such as Caffeine, Dextromethorphan, Omeprazole, and Midazolam are substrates for different enzymes (CYP1A2, CYP2D6, CYP2C19, and CYP3A). There is also information on "Fold Change" and "90% CI," but without additional context, it's not clear what those mean.*

figure5 - xelstrym 06

figure6 - xelstrym 07

Not available.*

Figure A (not to scale). - xelstrym 08

Figure A (not to scale). - xelstrym 09

The text is prompting the user to select one application site, which can be either the upper arm or the upper back.*

Figure A (not to scale). - xelstrym 10

Figure A (not to scale). - xelstrym 11

Figure A (not to scale). - xelstrym 12

Figure A (not to scale). - xelstrym 13

Figure A (not to scale). - xelstrym 14

Figure A (not to scale). - xelstrym 15

Figure A (not to scale). - xelstrym 16

Figure A (not to scale). - xelstrym 17

Figure A (not to scale). - xelstrym 18

Figure A (not to scale). - xelstrym 19

Figure A (not to scale). - xelstrym 20

Carton Label - 4.5 mg - xelstrym 21

Before using XELSTRYM, please read the Instructions for Use to learn how to apply, remove and dispose of the patch. The text below appears not to be relevant as it contains gibberish. The XELSTRYM is a transdermal system for Dextroamphetamine with a 4.5mg dosage for transdermal use only, available in a pack of 30 transdermal systems.*

Outer Carton Label - 9.0 mg - xelstrym 22

Before using XELSTRYM, refer to the Instructions for Use for guidance on how to apply, remove, and dispose of the patch. For additional details about the medication, consult the enclosed Medication Guide and Prescribing Information. The rest of the text is not available.*

Outer Carton Label - 13.5 mg - xelstrym 23

Xelstrym™ is a transdermal system containing 13.5 mg/9 hours of dextroamphetamine used for transdermal use only. The instruction manual must be read first before utilizing Xelstrym to learn how to apply, remove, and dispose of patches. The remaining text is not readable.*

Outer Carton Label - 18.0 mg - xelstrym 24

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.

Table of Contents